Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke: An analysis of 11,136 patients in Korea.
Kim SE, Lee H, Kim JY, Lee KJ, Kang J, Kim BJ, Han MK, Choi KH, Kim JT, Shin DI, Yeo MJ, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Park JM, Kang K, Kim JG, Lee SJ, Oh MS, Yu KH, Lee BC, Park HK, Hong KS, Cho YJ, Choi JC, Sohn SI, Hong JH, Park MS, Park TH, Park SS, Lee KB, Kwon JH, Kim WJ, Lee J, Lee JS, Lee J, Meretoja A, Gorelick PB, Bae HJ; CRCS-K Investigators.
Kim SE, et al. Among authors: sohn si.
Neurology. 2020 Mar 3;94(9):e978-e991. doi: 10.1212/WNL.0000000000009034. Epub 2020 Feb 6.
Neurology. 2020.
PMID: 32029544
OBJECTIVE: Stroke is a devastating and costly disease; however, there is a paucity of information on long-term costs and on how they differ according to 3-month modified Rankin scale (mRS) score, which is a primary outcome variable in acute stroke intervention trials. ...T …
OBJECTIVE: Stroke is a devastating and costly disease; however, there is a paucity of information on long-term costs and on how they …